Correlation Between Kiora Pharmaceuticals and Kezar Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and Kezar Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and Kezar Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and Kezar Life Sciences, you can compare the effects of market volatilities on Kiora Pharmaceuticals and Kezar Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of Kezar Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and Kezar Life.

Diversification Opportunities for Kiora Pharmaceuticals and Kezar Life

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between Kiora and Kezar is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and Kezar Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kezar Life Sciences and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with Kezar Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kezar Life Sciences has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and Kezar Life go up and down completely randomly.

Pair Corralation between Kiora Pharmaceuticals and Kezar Life

Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to under-perform the Kezar Life. But the stock apears to be less risky and, when comparing its historical volatility, Kiora Pharmaceuticals is 1.21 times less risky than Kezar Life. The stock trades about -0.02 of its potential returns per unit of risk. The Kezar Life Sciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  650.00  in Kezar Life Sciences on September 21, 2024 and sell it today you would earn a total of  2.00  from holding Kezar Life Sciences or generate 0.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Kiora Pharmaceuticals  vs.  Kezar Life Sciences

 Performance 
       Timeline  
Kiora Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kiora Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Kiora Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Kezar Life Sciences 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Kezar Life Sciences are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Kezar Life reported solid returns over the last few months and may actually be approaching a breakup point.

Kiora Pharmaceuticals and Kezar Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kiora Pharmaceuticals and Kezar Life

The main advantage of trading using opposite Kiora Pharmaceuticals and Kezar Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, Kezar Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will offset losses from the drop in Kezar Life's long position.
The idea behind Kiora Pharmaceuticals and Kezar Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal